These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 3109427)
1. Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells. Robichaud NJ; Fram RJ Biochem Pharmacol; 1987 May; 36(10):1673-7. PubMed ID: 3109427 [TBL] [Abstract][Full Text] [Related]
2. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells. Fram RJ; Robichaud N; Bishov SD; Wilson JM Cancer Res; 1987 Jul; 47(13):3360-5. PubMed ID: 3107809 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine. Swinnen LJ; Ellis NK; Erickson LC Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517 [TBL] [Abstract][Full Text] [Related]
4. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking. Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295 [TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of human gastric carcinoma cell growth by 1-beta-D-arabinofuranosylcytosine and hydroxyurea or 2'-deoxyguanosine in vitro. Matsumoto M; Kawahara T; Tsuda M; Ohkubo T; Kamiguchi H; Yamamura M Cancer Lett; 1992 Apr; 63(3):221-8. PubMed ID: 1576590 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside. Tanaka M; Kimura K; Yoshida S Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity. Rauscher F; Cadman E Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells. Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999 [TBL] [Abstract][Full Text] [Related]
9. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells. Bhalla K; Swerdlow P; Grant S Blood; 1991 Dec; 78(11):2937-44. PubMed ID: 1954383 [TBL] [Abstract][Full Text] [Related]
10. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin. Fram RJ; Kufe DW Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309 [TBL] [Abstract][Full Text] [Related]
11. Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway. Colly LP; Richel DJ; Arentsen-Honders MW; Kester MG; ter Riet PM; Willemze R Ann Hematol; 1992 Jul; 65(1):26-32. PubMed ID: 1643157 [TBL] [Abstract][Full Text] [Related]
12. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function. Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261 [TBL] [Abstract][Full Text] [Related]
13. The mode of action of 1-beta-D-arabinofuranosylcytosine in inhibiting DNA repair; new evidence using a sensitive assay for repair DNA synthesis and ligation in permeable cells. Gedik CM; Collins AR Mutat Res; 1991 May; 254(3):231-7. PubMed ID: 1904985 [TBL] [Abstract][Full Text] [Related]
14. Cellular and clinical pharmacology of low-dose ara-C. Kufe DW; Griffin JD; Spriggs DR Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
16. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines. Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosine. Howell SB; Streifel JA; Pfeifle CE Med Pediatr Oncol; 1982; 10 Suppl 1():81-91. PubMed ID: 6761570 [TBL] [Abstract][Full Text] [Related]
18. Effects of cis-diamminedichloroplatinum on DNA incorporation and cytotoxicity of 1-beta-D-arabinofuranosylcytosine. Spriggs DR; Robbins G; Kufe DW Biochem Pharmacol; 1986 Dec; 35(23):4297-302. PubMed ID: 3790154 [TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin. Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997 [TBL] [Abstract][Full Text] [Related]
20. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine. Grem JL; Allegra CJ Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]